SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
25 hedge funds and large institutions have $76.8M invested in Sinovac Biotech, Ltd in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
25
Holding in Top 10
3
Calls
$6K
Puts
–
Top Buyers
| 1 | +$127K | |
| 2 | +$72.1K | |
| 3 | +$10.1K | |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$8.95K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$585 |
Top Sellers
| 1 | -$137K | |
| 2 | -$92K | |
| 3 | -$83.7K | |
| 4 |
Morgan Stanley
New York
|
-$47K |
| 5 |
NA
Navellier & Associates
Reno,
Nevada
|
-$11.6K |